Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

SmithKline IBS Research Is One Of Nine Divestments Under FTC Order

Jan 01 2001

• By The Pink Sheet

Related Content

Glaxo Lotronex Withdrawal Follows Failed Risk Management Negotiations

Dec 04 2000

Novartis Zelmac DTC Ads To Emphasize Relief Of Abdominal Pain, Bloating

Dec 11 2000

SB Relinquishes Frovatriptan Royalties As Final Step In Antitrust Review

Dec 18 2000

Roche Kytril Acquisition From SmithKline Strengthens Hospital Focus In U.S.

Sep 04 2000

GlaxoSmithKline Merger Delayed While FTC Looks For "Smoking" Gun

Sep 18 2000

FDA Lotronex Letter Cites Desire To Work With Glaxo To Maintain Therapy

Jan 01 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window